ASSESSMENT OF CHANGES IN BIOCHEMICAL BLOOD PARAMETERS IN A PATIENT DIAGNOSED WITH LIVER CIRRHOSIS, USING AUTOLOGOUS MESENCHYMAL STEM CELLS
Abstract
About the Authors
I. E. KotkasRussian Federation
Sh. M. Asadulayev
Russian Federation
N. V. Marchenko
Russian Federation
N. I. Enukashvili
Russian Federation
References
1. Ludwig J., Viggiano T. R. Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease // Mayo Clin Proc. 1980, 55:434-8.
2. М. Карнейро де Мур. Неалкогольный стеатогепатит // Клинические перспективы в гастроэнтерологии, гепатологии. - 2001. - № 2. - С. 12-15.
3. Фадеенко Г. Д. Жировая печень: этиопатогенез, диагностика, лечение // Сучасна гастроентерологія. - 2003. - № 3(13). - С. 9-17.
4. Северов М. Неалкогольная жировая болезнь печени // Врач. - 2002. - № 10. - С. 23-26.,1212.
5. Bellentani S, Tinbelli C. Epidemiology and risk factors for fatty liver. In: Leuschner U. James OFW, Dancygier H (eds.). Steatohepatitis (NASH and ASH), Kluwer Academic Publishers, Dordrecht 2001, 3-10.].
6. Kantarcıoğlu M, Demirci H, Avcu F, Karslıoğlu Y, Babayiğit MA, Karaman B, Öztürk K, Gürel H, Akdoğan Kayhan M, Kaçar S, Kubar A, Öksüzoğlu G, Ural AU, Bağcı S.: Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis. The Turkish J ournal of gastroenterology 2015 May;26(3):244-50.
Review
For citations:
Kotkas I.E., Asadulayev Sh.M., Marchenko N.V., Enukashvili N.I. ASSESSMENT OF CHANGES IN BIOCHEMICAL BLOOD PARAMETERS IN A PATIENT DIAGNOSED WITH LIVER CIRRHOSIS, USING AUTOLOGOUS MESENCHYMAL STEM CELLS. Experimental and Clinical Gastroenterology. 2018;(2):174-176. (In Russ.)